A revolving door between FDA and the pharma industry raises questions about 'whether regulators indefatigably act in the public interest'

Submitted by Tech Insider on September 27, 2016 - 6:30pm

Greece Greek Pharmacist Drugs

To get a drug approved in the US, it has to pass through the regulatory hands of the Food and Drug Administration.

The process takes time, and there's a lot of communication between medical reviewers at the agency and the companies that are developing the drug.

But where do those medical reviewers go when they leave the FDA?

Pages

Subscribe to Front page feed